查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1961293

消化系统支架市场－全球产业规模、份额、趋势、机会、预测：按产品类型、应用、地区和竞争对手划分，2021-2031年

Gastrointestinal Stents Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Application, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球胃肠道支架市场预计将从 2025 年的 5.5719 亿美元成长到 2031 年的 7.7178 亿美元，复合年增长率为 5.58%。

这些可扩张的管状装置通常由金属或塑胶製成，旨在恢復消化道（例如胆管、结肠和食道）阻塞部位的管腔通畅性。市场成长的主要驱动因素包括全球消化器官系统恶性肿瘤发生率的上升以及老年人口的成长，老年人本身就更容易发生胃肠道阻塞。此外，临床上向微创内视镜手术的转变，与传统手术相比，微创内视镜手术的恢復时间更短，这也是推动产品需求的主要因素。

市场概览
预测期 2027-2031
市场规模：2025年 5.5719亿美元
市场规模：2031年 7.7178亿美元
复合年增长率：2026-2031年 5.58%
成长最快的细分市场 胃癌
最大的市场 北美洲

儘管存在这些市场驱动因素，但由于术后併发症（例如肿瘤生长、支架移位和阻塞）等问题，市场仍面临重大障碍，这可能会阻碍其广泛应用。相关疾病的严重负担凸显了有效处理阻塞的重要性。例如，美国癌症协会估计，到2025年，美国将新增154,270例大肠癌病例。如此庞大的病例数凸显了对可靠的支架治疗方案的迫切需求，以有效处理阻塞并提高患者的生活品质。

市场驱动因素

推动全球胃肠道支架市场成长的主要因素是胃肠道癌症（尤其是食道癌和胆道癌）发生率的上升。这些癌症需要姑息性支架置入术来恢復管腔通畅性。随着全球胃肠道癌症负担的加重，临床上对有效工具的需求日益增长，这些工具能够帮助无法手术切除的肿瘤患者缓解吞嚥困难和阻塞等症状。根据美国癌症协会于2025年1月发布的《2025年癌症事实与数据》报告，预计仅在美国就将新增约22,070例食道癌病例，这一数字直接增加了对耐用支架解决方案的需求，因为支架是癌症支持治疗的关键组成部分。

同时，随着医疗机构逐渐抛弃传统开放性手术，微创内视镜技术的日益普及也推动了市场的发展。先进支架设计的研发进一步促进了这一转变，这些设计能够实现更精准的放置并减少併发症，从而提高了手术量。该领域的经济实力体现在主要企业的业绩上。例如，波士顿科学公司在2025年2月发布的2024财年第四季及全年业绩报告中显示，其医疗外科部门（包括内视镜产品组合）的净销售额成长了12.4%。此外，Olympus在2025财年财务报告中录得调整后营业利润1885亿日元，充分展现了这些医疗技术所创造的巨大经济价值。

市场挑战

胃肠道支架术后併发症是市场成长的主要障碍，尤其是支架移位、肿瘤侵犯和阻塞。这些不利事件通常需要再次干预，加重患者的身体负担，并增加医疗保健系统的经济成本。当支架因移位或组织增生而无法维持管腔通畅性时，人们会认为这些装置的可靠性降低，导致医疗专业人员在建议使用支架治疗阻塞时更加谨慎。这可能会限製手术数量，并可能减缓支架的整体临床应用。

由于需要胆汁排放的疾病高发生，这些併发症的影响进一步加剧。在这种情况下，器械故障可能造成特别严重的危害。根据美国临床肿瘤学会 (ASCO) 估计，到 2024 年，美国将有 66,440 名成年人被诊断出罹患胰臟癌。由于胰臟恶性肿瘤常常导致胆道阻塞，需要置入支架，因此，在如此庞大的患者群体中，阻塞或移位的风险持续存在，这严重削弱了市场信心。这些不利事件的发生频率继续限制胃肠道支架市场的快速扩张。

市场趋势

腔内连接金属支架（LAMS）的出现彻底改变了胆道阻塞和胰液储存的治疗方式，实现了无需传统手术的治疗性引流。这些特殊的哑铃状装置可在胃肠道与相邻管腔之间建立稳定、临时的通道，显着简化了诸如管壁坏死等疾病的治疗。关键器材的商业性成功推动了介入治疗的普及。 2025年2月，波士顿科学公司在其2024年第四季及全年财务报告中宣布，其内视镜外科业务部门实现了两位数的成长。这项绩效主要归功于AXIOS支架平台的持续推广应用以及日本胆囊引流应用领域监管核准的扩大。

同时，生物可吸收和生物可降解支架的应用日益增多，旨在避免二次取出手术，并减少长期器械相关併发症。这些先进的支架设计为在维持管腔通畅性一段时间后逐渐溶解，从而降低永久性塑胶或金属支架常见的组织侵入和支架移位风险。随着这些器械临床疗效的证实，它们在标准治疗中的应用正在加速。例如，2025年发表于《Frontline Gastroenterology》的一篇题为「ERCP中生物可降解支架的应用：来自高发病率机构的启示」的论文，详细介绍了一项对132例患者的回顾性研究，证实了这些可溶解支架在治疗复杂胆道和胰管疾病方面的有效性，并确认了它们在减轻再次手术负担方面的作用。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：消化道支架全球市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 产品种类（胆道支架、结肠支架、十二指肠支架、食道支架、胰臟支架）
    • 依应用领域（胆道疾病、大肠癌、胃癌、发炎性肠道疾病等）
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美胃肠支架市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国别分析
    • 我们
    • 加拿大
    • 墨西哥

第七章：欧洲胃肠道支架市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国别分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区消化支架市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国别分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲消化支架市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东与非洲：国别分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美洲消化支架市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国别分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 促进因素
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 近期趋势

第十三章 全球消化道支架市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的议价能力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • Boston Scientific Corporation
  • Cook Group Inc.
  • Becton Dickinson & Co Ltd
  • CONMED Corporation
  • Cantel Medical LLC
  • ELLA-CS, sro
  • Hobbs Medical Inc.
  • Merit Medical Systems, Inc.
  • Olympus Corp.
  • Diagmed Healthcare Ltd.

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 20621

The Global Gastrointestinal Stents Market is projected to expand from USD 557.19 Million in 2025 to USD 771.78 Million by 2031, reflecting a compound annual growth rate of 5.58%. These expandable tubular devices, generally constructed from metal or plastic, are engineered to re-establish luminal patency in blocked sections of the digestive tract, such as the biliary tree, colon, and esophagus. Market growth is principally driven by the increasing global prevalence of gastrointestinal malignancies and a growing elderly population that is inherently more prone to digestive blockages. Additionally, the clinical transition toward minimally invasive endoscopic procedures, which provide faster recovery times compared to conventional surgery, acts as a key catalyst for product demand.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 557.19 Million
Market Size 2031USD 771.78 Million
CAGR 2026-20315.58%
Fastest Growing SegmentStomach Cancer
Largest MarketNorth America

Despite these drivers, the market faces significant hurdles due to post-procedural complications like tumor ingrowth, stent migration, and occlusion, which can hinder broader adoption. The critical need for effective obstruction management is underscored by the heavy burden of associated diseases; for instance, the American Cancer Society estimated that 154,270 new cases of colorectal cancer would be diagnosed in the United States in 2025. This substantial volume of diagnoses highlights the urgent necessity for reliable stenting solutions to manage obstructions effectively and enhance the quality of life for patients.

Market Driver

The primary factor accelerating the Global Gastrointestinal Stents Market is the rising incidence of gastrointestinal cancers, specifically esophageal and biliary malignancies, which require palliative stenting to restore luminal patency. As the global burden of digestive cancers grows, there is an intensified clinical need for effective tools to manage symptoms like dysphagia and blockages in patients with inoperable tumors. According to the 'Cancer Facts & Figures 2025' report released by the American Cancer Society in January 2025, approximately 22,070 new cases of esophageal cancer were projected to be diagnosed in the United States alone, a figure that directly increases the demand for durable stenting solutions as a vital part of supportive oncology care.

Simultaneously, the market is being propelled by a growing preference for minimally invasive endoscopic techniques as healthcare providers move away from traditional open surgeries. This shift is supported by the development of advanced stent designs that allow for more precise placement and fewer complications, thereby encouraging higher procedure volumes. The economic strength of this sector is reflected in the performance of major industry players; for example, Boston Scientific reported a 12.4% increase in net sales for its MedSurg segment, which includes its endoscopy portfolio, in its 'Fourth Quarter and Full Year 2024 Financial Results' in February 2025. Furthermore, Olympus recorded an adjusted operating profit of ¥188.5 billion in its 2025 fiscal year results, demonstrating the significant economic value generated by these medical technologies.

Market Challenge

A critical obstacle impeding market growth involves the post-procedural complications associated with gastrointestinal stents, particularly stent migration, tumor ingrowth, and occlusion. These adverse events frequently require repeat interventions, which increase the physical strain on patients and add financial costs to healthcare systems. When stents fail to maintain luminal patency due to displacement or tissue overgrowth, the perceived reliability of these devices diminishes, leading healthcare providers to exercise caution in recommending stenting for obstruction management, which potentially limits procedural volumes and slows overall clinical adoption.

The impact of these complications is exacerbated by the high prevalence of conditions requiring biliary drainage, where device failure can be especially detrimental. According to the American Society of Clinical Oncology, an estimated 66,440 adults in the United States were diagnosed with pancreatic cancer in 2024. Since pancreatic malignancies often cause biliary obstructions that necessitate stenting, the persistent risk of occlusion or migration within such a large patient population creates a significant barrier to market confidence, with the frequency of these adverse events continuing to restrain the aggressive expansion of the gastrointestinal stents market.

Market Trends

The emergence of Lumen-Apposing Metal Stents (LAMS) is revolutionizing the management of biliary obstructions and pancreatic fluid collections by enabling therapeutic drainage without the need for traditional surgery. These specialized dumbbell-shaped devices establish a stable, temporary conduit between the gastrointestinal tract and adjacent cavities, significantly simplifying procedures for conditions such as walled-off necrosis. This shift toward interventional solutions is evidenced by the commercial success of leading device platforms; in February 2025, Boston Scientific reported in its 'Fourth Quarter and Full Year 2024 Financial Results' that its endoluminal surgery franchise achieved double-digit growth, a performance attributed to the sustained adoption of the AXIOS stent platform and its expanded regulatory approval for gallbladder drainage in Japan.

In parallel, the adoption of bioresorbable and biodegradable stents is increasing as a solution to eliminate the need for secondary removal procedures and reduce long-term device-related complications. These advanced stents are engineered to maintain luminal patency for a specific period before gradually dissolving, thereby mitigating risks such as tissue ingrowth and stent migration that are frequently associated with permanent plastic or metal alternatives. The clinical validation of these devices is accelerating their integration into standard practice; for instance, a 2025 article in Frontline Gastroenterology titled 'Use of biodegradable stents in ERCP: lessons from a single high-volume centre' detailed a retrospective study of 132 patients that demonstrated the effectiveness of these dissolving stents for complex biliary and pancreatic indications, confirming their utility in lowering the burden of repeat interventions.

Key Market Players

  • Boston Scientific Corporation
  • Cook Group Inc.
  • Becton Dickinson & Co Ltd
  • CONMED Corporation
  • Cantel Medical LLC
  • ELLA-CS, s.r.o.
  • Hobbs Medical Inc.
  • Merit Medical Systems, Inc.
  • Olympus Corp.
  • Diagmed Healthcare Ltd.

Report Scope

In this report, the Global Gastrointestinal Stents Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Gastrointestinal Stents Market, By Product Type

  • Biliary Stent
  • Colonic Stent
  • Duodenal Stent
  • Esophageal Stent
  • Pancreatic Stent

Gastrointestinal Stents Market, By Application

  • Biliary Disease
  • Colorectal Cancer
  • Stomach Cancer
  • Inflammatory Bowel Disease
  • Others

Gastrointestinal Stents Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Gastrointestinal Stents Market.

Available Customizations:

Global Gastrointestinal Stents Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Gastrointestinal Stents Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (Biliary Stent, Colonic Stent, Duodenal Stent, Esophageal Stent, Pancreatic Stent)
    • 5.2.2. By Application (Biliary Disease, Colorectal Cancer, Stomach Cancer, Inflammatory Bowel Disease, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Gastrointestinal Stents Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Gastrointestinal Stents Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Gastrointestinal Stents Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Gastrointestinal Stents Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By Application

7. Europe Gastrointestinal Stents Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Gastrointestinal Stents Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Application
    • 7.3.2. France Gastrointestinal Stents Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Gastrointestinal Stents Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Gastrointestinal Stents Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Gastrointestinal Stents Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By Application

8. Asia Pacific Gastrointestinal Stents Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Gastrointestinal Stents Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Application
    • 8.3.2. India Gastrointestinal Stents Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Gastrointestinal Stents Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Gastrointestinal Stents Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Gastrointestinal Stents Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By Application

9. Middle East & Africa Gastrointestinal Stents Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Gastrointestinal Stents Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Application
    • 9.3.2. UAE Gastrointestinal Stents Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Application
    • 9.3.3. South Africa Gastrointestinal Stents Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Application

10. South America Gastrointestinal Stents Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Gastrointestinal Stents Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Application
    • 10.3.2. Colombia Gastrointestinal Stents Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Application
    • 10.3.3. Argentina Gastrointestinal Stents Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Gastrointestinal Stents Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Boston Scientific Corporation
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Cook Group Inc.
  • 15.3. Becton Dickinson & Co Ltd
  • 15.4. CONMED Corporation
  • 15.5. Cantel Medical LLC
  • 15.6. ELLA-CS, s.r.o.
  • 15.7. Hobbs Medical Inc.
  • 15.8. Merit Medical Systems, Inc.
  • 15.9. Olympus Corp.
  • 15.10. Diagmed Healthcare Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer